What is the price-to-earnings ratio of Lupin?
The price-earnings ratio of Lupin is currently 4.36.
Lupin P/S 2025
Lupin P/S
4.36
Ticker
LUPIN.NS
ISIN
INE326A01037
As of Feb 9, 2025, Lupin's P/S ratio stood at 4.36, a 20.44% change from the 3.62 P/S ratio recorded in the previous year.
The Lupin P/S history
Lupin Aktienanalyse
What does Lupin do?
Lupin Limited is an Indian pharmaceutical company specializing in generics and novel therapies. It was founded in 1968 by Dr. Desh Bandhu Gupta and has experienced rapid growth, becoming one of the leading companies in the global pharmaceutical market. The company's business model involves manufacturing and marketing generics and novel therapies for the treatment of various diseases such as cancer, diabetes, cardiovascular diseases, and respiratory diseases. Lupin operates worldwide with a wide range of partners to distribute its products in over 100 countries. The company is involved in various divisions including generics, novel therapies, biosimilars, and inhalation products. Lupin's generics division encompasses a wide range of products such as antibiotics, antidepressants, antihypertensives, and many other categories. Its novel therapies include innovative products for the treatment of diabetes, cancer, multiple sclerosis, and other chronic diseases. Lupin is also involved in the development of biosimilars, which are imitation biopharmaceuticals manufactured using living organisms. Lastly, the company offers inhalation products for the treatment of respiratory diseases such as asthma and COPD. Lupin has built an impressive product pipeline over the years, having submitted over 174 ANDA applications (for the approval of new generics) to the US FDA and introduced more than 80 new products in the Indian market. It has also established an innovative research and development center that focuses on the discovery of new molecules and the development of new therapeutic approaches. Another important feature of Lupin is its commitment to quality and sustainability. The company has received numerous awards for its product quality and environmental initiatives. In 2019, Lupin received the Sustainable Business Award from CNBC TV18. Overall, Lupin Limited is a successful and fast-growing company specializing in generics and novel therapies. It has a wide range of products and an impressive pipeline, and operates globally. Due to its commitment to quality and sustainability, Lupin Limited has also built a strong reputation among its customers and partners. Lupin ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/S Details
Decoding Lupin's P/S Ratio
Lupin's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.
Year-to-Year Comparison
Comparing Lupin's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.
Impact on Investments
The P/S ratio is instrumental for investors evaluating Lupin's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.
Interpreting P/S Ratio Fluctuations
Variations in Lupin’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.
Frequently Asked Questions about Lupin stock
How has the price-earnings ratio of Lupin changed compared to last year?
The price-to-earnings ratio of Lupin has increased by 20.44% increased compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Lupin high compared to other companies?
Yes, the price-to-earnings ratio of Lupin is high compared to other companies.
How does an increase in the price-earnings ratio of Lupin affect the company?
An increase in the price-earnings ratio of Lupin would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Lupin affect the company?
A decrease in the price-earnings ratio of Lupin would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Lupin?
Some factors that influence the price-earnings ratio of Lupin are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Lupin pay?
Over the past 12 months, Lupin paid a dividend of 8 INR . This corresponds to a dividend yield of about 0.36 %. For the coming 12 months, Lupin is expected to pay a dividend of 7.42 INR.
What is the dividend yield of Lupin?
The current dividend yield of Lupin is 0.36 %.
When does Lupin pay dividends?
Lupin pays a quarterly dividend. This is distributed in the months of August, August, August, August.
How secure is the dividend of Lupin?
Lupin paid dividends every year for the past 23 years.
What is the dividend of Lupin?
For the upcoming 12 months, dividends amounting to 7.42 INR are expected. This corresponds to a dividend yield of 0.34 %.
In which sector is Lupin located?
Lupin is assigned to the 'Health' sector.
Wann musste ich die Aktien von Lupin kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Lupin from 9/1/2024 amounting to 8 INR, you needed to have the stock in your portfolio before the ex-date on 7/16/2024.
When did Lupin pay the last dividend?
The last dividend was paid out on 9/1/2024.
What was the dividend of Lupin in the year 2024?
In the year 2024, Lupin distributed 4 INR as dividends.
In which currency does Lupin pay out the dividend?
The dividends of Lupin are distributed in INR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Lupin
Our stock analysis for Lupin Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Lupin Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.